In vitro assessment of nanosilver-functionalized PMMA bone cement on primary human mesenchymal stem cells and osteoblasts

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Pauksch, Linda ^a   Hartmann, Sonja ^a   Szalay, Gabor ^b   Alt, Volker ^b   Lips, Katrin S ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE CEMENT; GENTAMICIN; POLYMETHYLMETHACRYLATE BONE CEMENT; SILVER NANOPARTICLE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; MESSENGER RNA; NANOPARTICLE; POLY(METHYL METHACRYLATE); SILVER;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CELL COUNT; CELL DIFFERENTIATION; CELL GROWTH; CELL STRESS; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DEFENSE MECHANISM; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; REAL TIME POLYMERASE CHAIN REACTION; APOPTOSIS; BONE DEVELOPMENT; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENETICS; MATERIALS TESTING; MESENCHYMAL STROMA CELL; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; APOPTOSIS; BONE CEMENTS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; GENTAMICINS; HUMANS; IN VITRO TECHNIQUES; MATERIALS TESTING; MESENCHYMAL STROMAL CELLS; NANOPARTICLES; OSTEOBLASTS; OSTEOGENESIS; POLYMETHYL METHACRYLATE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SILVER;

EID: 84915822735     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114740     Document Type: Article

References (53)

1. Campoccia D, Montanaro L, Arciola CR (2006) The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 27: 2331-2339.
2. Matar WY, Jafari SM, Restrepo C, Austin M, Purtill JJ, et al. (2010) Preventing infection in total joint arthroplasty. J Bone Joint Surg Am 92 Suppl 2: 36-46.
3. Garvin KL, Hanssen AD (1995) Infection after total hip arthroplasty. Past, present, and future. J Bone Joint Surg Am 77: 1576-1588.
4. Hanssen AD, Rand JA (1999) Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect 48: 111-122.
5. Renaud A, Lavigne M, Vendittoli PA (2012) Periprosthetic joint infections at a teaching hospital in 1990-2007. Can J Surg 55: 394-400.
6. Darwiche H, Barsoum WK, Klika A, Krebs VE, Molloy R (2010) Retrospective analysis of infection rate after early reoperation in total hip arthroplasty. Clin Orthop Relat Res 468: 2392-2396.
7. Jafari SM, Coyle C, Mortazavi SM, Sharkey PF, Parvizi J (2010) Revision hip arthroplasty: infection is the most common cause of failure. Clin Orthop Relat Res 468: 2046-2051.
8. Trampuz A, Zimmerli W (2005) Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly 135: 243-251.
9. Moreira-Gonzalez A, Jackson IT, Miyawaki T, Barakat K, DiNick V (2003) Clinical outcome in cranioplasty: critical review in long-term follow-up. J Craniofac Surg 14: 144-153.
10. Lentino JR (2003) Prosthetic joint infections: Bane of orthopedists, challenge for infectious disease specialists. Clinical Infectious Diseases 36: 1157-1161.
11. Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, et al. (1998) Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 27: 1247-1254.
12. Gristina AG (1994) Implant failure and the immuno-incompetent fibro-inflammatory zone. Clin Orthop Relat Res: 106-118.
13. Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351: 1645-1654.
14. Lentino JR (2004) Infections Associated with Prosthetic Knee and Prosthetic Hip. Curr Infect Dis Rep 6: 388-392.
15. Chang Y, Tai CL, Hsieh PH, Ueng SW (2013) Gentamicin in bone cement: A potentially more effective prophylactic measure of infectionin joint arthroplasty. Bone Joint Res 2: 220-226.
16. van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, et al. (2001) Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand 72: 557-571.
17. Galvez-Lopez R, Pena-Monje A, Antelo-Lorenzo R, Guardia-Olmedo J, Moliz J, et al. (2014) Elution kinetics, antimicrobial activity, and mechanical properties of 11 different antibiotic loaded acrylic bone cement. Diagn Microbiol Infect Dis 78: 70-74.
18. Okafor F, Janen A, Kukhtareva T, Edwards V, Curley M (2013) Green synthesis of silver nanoparticles, their characterization, application and antibacterial activity. Int J Environ Res Public Health 10: 5221-5238.
19. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, et al. (2007) Antimicrobial effects of silver nanoparticles. Nanomedicine 3: 95-101.
20. Choi O, Deng KK, Kim NJ, Ross L Jr, Surampalli RY, et al. (2008) The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res 42: 3066-3074.
21. Martinez-Gutierrez F, Olive PL, Banuelos A, Orrantia E, Nino N, et al. (2010) Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles. Nanomedicine 6: 681-688.
22. Kalishwaralal K, BarathManiKanth S, Pandian SR, Deepak V, Gurunathan S (2010) Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B Biointerfaces 79: 340-344.
23. Mohanty S, Mishra S, Jena P, Jacob B, Sarkar B, et al. (2012) An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomedicine-Nanotechnology Biology and Medicine 8: 916-924.
24. Wright JB, Lam K, Burrell RE (1998) Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. Am J Infect Control 26: 572-577.
25. Samberg ME, Orndorff PE, Monteiro-Riviere NA (2011) Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicology 5: 244-253.
26. Lara HH, Ayala-Nunez NV, Turrent LDI, Padilla CR (2010) Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World Journal of Microbiology & Biotechnology 26: 615-621.
27. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, et al. (2000) A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. Journal of Biomedical Materials Research 52: 662-668.
28. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, et al. (2005) The bactericidal effect of silver nanoparticles. Nanotechnology 16: 2346-2353.
29. Sondi I, Salopek-Sondi B (2004) Silver nanoparticles as antimicrobial agent: a case study on E-coli as a model for Gram-negative bacteria. Journal of Colloid and Interface Science 275: 177-182.
30. Klein CL, Comero S, Stahlmecke B, Romazanov J, Kuhlbusch TAJ, et al. (2011) NM-Series of Representative Manufactured Nanomaterials. NM-300 Silver. Characterisation, Stability, Homogeneity. JRC Scientific and Technical Reports [Online] Available: http://publications.jrc.ec.europa.eu/repository/bitstream/.111111111/16076/1/60709%20final-report-nm-300-08-09-2010%20final%202011%.
31. Pauksch L, Hartmann S, Rohnke M, Szalay G, Alt V, et al. (2014) Biocompatibility of silver nanoparticles and silver ions in primary human mesenchymal stem cells and osteoblasts. Acta Biomater 10: 439-449.
32. Alt V, Bechert T, Steinrucke P, Wagener M, Seidel P, et al. (2004) An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 25: 4383-4391.
33. Chang Y, Goldberg VM, Caplan AI (2006) Toxic effects of gentamicin on marrow-derived human mesenchymal stem cells. Clin Orthop Relat Res 452: 242-249.
34. Ince A, Schutze N, Karl N, Lohr JF, Eulert J (2007) Gentamicin negatively influenced osteogenic function in vitro. Int Orthop 31: 223-228.
35. Albers CE, Hofstetter W, Siebenrock KA, Landmann R, Klenke FM (2013) In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations. Nanotoxicology 7: 30-36.
36. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, et al. (2006) Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7: 14.
37. Kim J, Kang JW, Park JH, Choi Y, Choi KS, et al. (2009) Biological characterization of long-term cultured human mesenchymal stem cells. Arch Pharm Res 32: 117-126.
38. Stenderup K, Justesen J, Clausen C, Kassem M (2003) Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33: 919-926.
39. Abdallah BM, Haack-Sorensen M, Fink T, Kassem M (2006) Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone 39: 181-188.
40. Kassem M, Abdallah BM, Saeed H (2008) Osteoblastic cells: differentiation and trans-differentiation. Arch Biochem Biophys 473: 183-187.
41. Rathbone CR, Cross JD, Brown KV, Murray CK, Wenke JC (2011) Effect of various concentrations of antibiotics on osteogenic cell viability and activity. J Orthop Res 29: 1070-1074.
42. Hackenberg S, Scherzed A, Kessler M, Hummel S, Technau A, et al. (2011) Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol Lett 201: 27-33.
43. Greulich C, Kittler S, Epple M, Muhr G, Koller M (2009) Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs). Langenbecks Arch Surg 394: 495-502.
44. Teodoro JS, Simoes AM, Duarte FV, Rolo AP, Murdoch RC, et al. (2011) Assessment of the toxicity of silver nanoparticles in vitro: a mitochondrial perspective. Toxicol In Vitro 25: 664-670.
45. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, et al. (2008) Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 112: 13608-13619.
46. Singh RP, Ramarao P (2012) Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles. Toxicol Lett 213: 249-259.
47. Samberg ME, Loboa EG, Oldenburg SJ, Monteiro-Riviere NA (2012) Silver nanoparticles do not influence stem cell differentiation but cause minimal toxicity. Nanomedicine (Lond) 7: 1197-1209.
48. Liu X, He W, Fang Z, Kienzle A, Feng Q (2014) Influence of silver nanoparticles on osteogenic differentiation of human mesenchymal stem cells. J Biomed Nanotechnol 10: 1277-1285.
49. Qin H, Zhu C, An Z, Jiang Y, Zhao Y, et al. (2014) Silver nanoparticles promote osteogenic differentiation of human urine-derived stem cells at noncytotoxic concentrations. Int J Nanomedicine 9: 2469-2478.
50. Isefuku S, Joyner CJ, Simpson AH (2003) Gentamicin may have an adverse effect on osteogenesis. J Orthop Trauma 17: 212-216.
51. Ahamed MI, Sankar S, Kashif PM, Basha SK, Sastry TP (2014) Evaluation of biomaterial containing regenerated cellulose and chitosan incorporated with silver nanoparticles. Int J Biol Macromol 72C: 680-686.
52. Arora M, Chan EK, Gupta S, Diwan AD (2013) Polymethylmethacrylate bone cements and additives: A review of the literature. World J Orthop 4: 67-74.
53. Zhang R, Piao MJ, Kim KC, Kim AD, Choi JY, et al. (2012) Endoplasmic reticulum stress signaling is involved in silver nanoparticles-induced apoptosis. Int J Biochem Cell Biol 44: 224-232.